Beijing IDMO

Beijing IDMO is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the cell and gene therapy (CGT) sector. The company provides end-to-end solutions ranging from early-stage process development and analytical testing to large-scale GMP manufacturing of viral vectors, plasmids, and cell therapy products. Beijing IDMO operates state-of-the-art facilities designed to meet international regulatory standards, supporting biotech and pharmaceutical clients in accelerating their clinical pipelines. Their expertise spans various modalities including CAR-T, TCR-T, and mRNA technologies, positioning them as a key infrastructure provider in the Chinese and global regenerative medicine landscape.